Substance P expression in TRPV 1 and trkA-positive dorsal root ganglion neurons innervating the mouse lung

被引:68
作者
Dinh, QT
Groneberg, DA
Peiser, C
Mingomataj, E
Joachim, RA
Witt, C
Arck, PC
Klapp, BE
Fischer, A
机构
[1] Humboldt Univ, Dept Med, Charite, Sch Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Clin Res Unit Allergy, Charite, Sch Med, D-13353 Berlin, Germany
[3] Humboldt Univ, Dept Pneumol, Charite, Sch Med, D-13353 Berlin, Germany
关键词
airway; corresponding dorsal root ganglia; mammals; mouse; mediators; substance P; receptors; TRPV; 1; trkA;
D O I
10.1016/j.resp.2004.08.001
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
In the present study, the co-localisation of substance P (SP) with the vanilloid receptor TRPV1 and the neurotrophin receptor tyrosine kinase trkA was analysed in airway-specific murine dorsal root ganglion (DRG) neurons. DRG neurons labelled with Fast Blue were predominantly found at the segmental levels T2-T5. Immunoreactivity for the receptor TRPV1 was localized to 12% of Fast Blue labelled DRG neurons. Double-labelling immunohistochemistry revealed that a substantial number of them also co-express SP (7.6 +/- 1.1% (mean +/- S.E.M.)), whereas neurons with immunoreactivity for TRPV1 only were found in 4.4 +/- 1.3% of the retrogradely labelled neuronal population. Further analysis of retrogradely labelled neurons showed that their majority expressed trkA (62.8 +/- 1.4%), neurotilament protein 68-kDa (64.8 +/- 1.5%) or glutamate alone (19.5 +/- 1.9%). SP was always expressed in trkA-positive neurons. Based on the extent of co-localization of SP with the receptors TRPV1 and trkA in DRG airway neurons, the present study indicates that the DRG pathway may have effects on the magnitude of neurogenic inflammation in airway diseases such as asthma. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 41 条
[1]
Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons [J].
Amaya, F ;
Oh-Hashi, K ;
Naruse, Y ;
Iijima, N ;
Ueda, M ;
Shimosato, G ;
Tominaga, M ;
Tanaka, Y ;
Tanaka, M .
BRAIN RESEARCH, 2003, 963 (1-2) :190-196
[2]
Neurogenic inflammation in the airways [J].
Barnes, PJ .
RESPIRATION PHYSIOLOGY, 2001, 125 (1-2) :145-154
[3]
trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurones in the rat [J].
Bennett, DL ;
Dmietrieva, N ;
Priestley, JV ;
Clary, D ;
McMahon, SB .
NEUROSCIENCE LETTERS, 1996, 206 (01) :33-36
[4]
PULMONARY STRETCH-RECEPTOR AFFERENTS ACTIVATE EXCITATORY AMINO-ACID RECEPTORS IN THE NUCLEUS-TRACTUS-SOLITARII IN RATS [J].
BONHAM, AC ;
COLES, SK ;
MCCRIMMON, DR .
JOURNAL OF PHYSIOLOGY-LONDON, 1993, 464 :725-745
[5]
Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma [J].
Bonini, S ;
Lambiase, A ;
Bonini, S ;
Angelucci, F ;
Magrini, L ;
Manni, L ;
Aloe, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10955-10960
[6]
Nerve growth factor and asthma [J].
Bonini, S ;
Lambiase, A ;
Properzi, F ;
Bresciani, M ;
Bracci-Laudiero, L ;
Mancini, MJ ;
Procoli, A ;
Micera, A ;
Sacerdoti, G ;
Bonini, S ;
Levi-Schaffer, F ;
Rasi, G ;
Aloe, L .
ALLERGY, 2002, 57 :13-15
[7]
The capsaicin receptor: a heat-activated ion channel in the pain pathway [J].
Caterina, MJ ;
Schumacher, MA ;
Tominaga, M ;
Rosen, TA ;
Levine, JD ;
Julius, D .
NATURE, 1997, 389 (6653) :816-824
[8]
Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs [J].
de Vries, A ;
Dessing, MC ;
Engels, F ;
Henricks, PAJ ;
Nijkamp, FP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (05) :1541-1544
[9]
Expression of substance P and vanilloid receptor (VR1) in trigeminal sensory neurons projecting to the mouse nasal mucosa [J].
Dinh, QT ;
Groneberg, DA ;
Mingomataj, E ;
Peiser, C ;
Heppt, W ;
Dinh, S ;
Arck, PC ;
Klapp, BF ;
Fischer, A .
NEUROPEPTIDES, 2003, 37 (04) :245-250
[10]
Mediators of asthma: Nitric oxide [J].
Fischer, A ;
Folkerts, G ;
Geppetti, P ;
Groneberg, DA .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2002, 15 (02) :73-81